Literature DB >> 1543564

Antibodies and complement enhance binding and uptake of HIV-1 by human monocytes.

L J Bakker1, H S Nottet, N M de Vos, L de Graaf, J A Van Strijp, M R Visser, J Verhoef.   

Abstract

OBJECTIVE: To characterize antibody- and complement-mediated binding and uptake of HIV-1 by human monocytes.
DESIGN: The first step in the infection of the monocyte by HIV-1 is binding of the virus to the susceptible cell. Procedures were designed to assess the influence of anti-HIV-1 antibodies and complement on this binding, and to study the process of internalization following binding.
METHODS: Human monocytes were incubated with fluorescein-labelled purified HTLV-IIIB virions and human sera with high-titre anti-HIV-1 antibodies and/or complement. Binding and uptake of virus by the monocytes was measured as fluorescence per cell by flow cytometry.
RESULTS: Binding of purified HIV-1 to monocytes was increased by complement and, to a lesser extent, by anti-HIV-1 antibodies. Uptake of HIV-1 bound to the monocyte appeared to be mediated by antibodies and was increased further by the presence of complement. Complement alone, however, resulted in the uptake of only a small part of the bound virus.
CONCLUSIONS: Complement significantly increases the binding of HIV-1 to human monocytes, and a combination of antibodies and complement efficiently mediates uptake of HIV-1 by monocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1543564     DOI: 10.1097/00002030-199201000-00004

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

Review 1.  Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.

Authors:  D C Montefiori
Journal:  Springer Semin Immunopathol       Date:  1997

2.  Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients.

Authors:  Ramu A Subbramanian; Jingwu Xu; Emil Toma; Richard Morisset; Eric A Cohen; José Menezes; Ali Ahmad
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  Neurologic disease in captive lions (Panthera leo) with low-titer lion lentivirus infection.

Authors:  Greg Brennan; Michael D Podell; Raymund Wack; Susan Kraft; Jennifer L Troyer; Helle Bielefeldt-Ohmann; Sue VandeWoude
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

4.  CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4.

Authors:  N Thieblemont; N Haeffner-Cavaillon; A Ledur; J L'Age-Stehr; H W Ziegler-Heitbrock; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

5.  Antibody to ICAM-1 mediates enhancement of HIV-1 infection of human endothelial cells.

Authors:  O Scheglovitova; V Scanio; S Fais; S Papadia; I Abbate; C Castilletti; F Dianzani; M R Capobianchi
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

6.  CD4-independent binding of HIV-1 to the B lymphocyte receptor CR2 (CD21) in the presence of complement and antibody.

Authors:  D C Montefiori; J Zhou; D I Shaff
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

7.  Increased adhesion as a mechanism of antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus infection.

Authors:  O Lund; J Hansen; A M Søorensen; E Mosekilde; J O Nielsen; J E Hansen
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.